About Carmenta Bio
Carmenta Bio is a company based in Palo Alto (United States) founded in 2012 was acquired by Progenity in April 2015. Carmenta Bio has raised $2.59 million across 2 funding rounds from investors including Progenity. Carmenta Bio operates in a competitive market with competitors including Celmatix, Metabolomic Diagnostics, adyn, LIA Diagnostics and Confer Health, among others.
- Headquarter Palo Alto, United States
- SectorsHealthcare
- Website carmentabio.com
- Social LinkedIn X Facebook
- Acquired by Progenity (Apr 2015)
- Legal Name Carmenta Bioscience Inc
Funding Insights of Carmenta Bio
Carmenta Bio has successfully raised a total of $2.59M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2 million completed in August 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.59M
- Total Rounds 2
- Last Round Seed — $2M
- First Round $585,866
(Jul 2013)
All 2 funding rounds of Carmenta Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2013 | $2M | Seed | – | – | – |
| Jul 2013 | $585,866 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Carmenta Bio
Carmenta Bio has secured backing from 1 investor. Prominent investors backing the company include Progenity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Non-invasive prenatal genomic testing is provided for genetic disorders. | 2011 | progenity.com | San Diego, United States |
Investor details for Carmenta Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Carmenta Bio
4 dated milestones of Carmenta Bio across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Carmenta Bio is founded.
- Funding First funding round of $586K.
- Funding Latest funding round, Seed, of $2.0M.
- Exit Acquired by Progenity.
Competitors of Carmenta Bio
Carmenta Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, Metabolomic Diagnostics, adyn, LIA Diagnostics and Confer Health, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celmatix.com | 2009 | New York, United States | $24.89M | 27 | Fertility decisions are optimized using data analytics and genomics. | |
| metabolomicdiagnostics.com | 2011 | Cork, Ireland | $3.89M | – | Diagnostics and prognostics for maternal health are developed using metabolomics. | |
| adyn.com | 2019 | Seattle, United States | $2.65M | – | Provider of DNA and hormone analysis based birth control optimization kits | |
| liadiagnostics.com | 2015 | Philadelphia, United States | $4.22M | – | Disposable paper pregnancy test kits | |
| confer.health | 2015 | Boston, United States | $9.5M | – | Clinical-grade diagnostic tests for home use are developed. | |
| milulabs.com | 2018 | New York, United States | – | – | Exosome-based diagnostic products for health screening are offered. | |
| firstresponse.com | 1999 | Princeton, United States | – | – | Provides pregnancy tests, fertility lubricants, and planning tools for conception. | |
| jabrehoo.com | 2011 | Beijing, China | $14.35M | – | Next-generation sequencing services for assisted reproduction are integrated. |
Detailed competitors of Carmenta Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Carmenta Bio
10 companies that operate in the same segment as Carmenta Bio (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 124.07 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 47 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Carmenta Bio
Carmenta Bio was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Carmenta Bio is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Carmenta Bio is a funded company, having raised a total of $2.59M across 2 funding rounds to date. The company's 1st funding round was a Seed of $585.87K, raised on Jul 2013.
Carmenta Bio was founded in 2012 in Palo Alto, United States, as a Stanford spin-out focused on biotechnology for womens health. Proprietary computational algorithms were combined with protein sera measurements in its platform to enable maternal diagnostics. A diagnostic test for preeclampsia was offered for both symptomatic and asymptomatic expectant mothers. The company was acquired by Progenity in April 2015.
Carmenta Bio's top competitors include Celmatix, Metabolomic Diagnostics and LIA Diagnostics.
Carmenta Bio has 1 investor. Key investors include Progenity.
Carmenta Bio operates through Carmenta Bioscience Inc.
Yes. Carmenta Bio was acquired by Progenity in April 2015.